| Product Code: ETC10162287 | Publication Date: Apr 2025 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Bhawna Singh | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Thailand Atherosclerotic Cardiovascular Disease Market Overview |
3.1 Thailand Country Macro Economic Indicators |
3.2 Thailand Atherosclerotic Cardiovascular Disease Market Revenues & Volume, 2021 & 2031F |
3.3 Thailand Atherosclerotic Cardiovascular Disease Market - Industry Life Cycle |
3.4 Thailand Atherosclerotic Cardiovascular Disease Market - Porter's Five Forces |
3.5 Thailand Atherosclerotic Cardiovascular Disease Market Revenues & Volume Share, By Disease Area, 2021 & 2031F |
3.6 Thailand Atherosclerotic Cardiovascular Disease Market Revenues & Volume Share, By Treatment Type, 2021 & 2031F |
3.7 Thailand Atherosclerotic Cardiovascular Disease Market Revenues & Volume Share, By Therapeutic Approach, 2021 & 2031F |
3.8 Thailand Atherosclerotic Cardiovascular Disease Market Revenues & Volume Share, By Risk Factors, 2021 & 2031F |
4 Thailand Atherosclerotic Cardiovascular Disease Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of risk factors such as obesity and unhealthy diet leading to a rise in atherosclerotic cardiovascular diseases. |
4.2.2 Growing aging population in Thailand contributing to a higher incidence of cardiovascular diseases. |
4.2.3 Advancements in healthcare infrastructure and technology improving diagnosis and treatment options for atherosclerotic cardiovascular diseases. |
4.3 Market Restraints |
4.3.1 High cost associated with cardiovascular disease treatments and procedures limiting access to care for some individuals. |
4.3.2 Lack of awareness about preventive measures and lifestyle changes to reduce the risk of atherosclerotic cardiovascular diseases. |
4.3.3 Limited reimbursement policies and insurance coverage for cardiovascular disease treatments impacting affordability for patients. |
5 Thailand Atherosclerotic Cardiovascular Disease Market Trends |
6 Thailand Atherosclerotic Cardiovascular Disease Market, By Types |
6.1 Thailand Atherosclerotic Cardiovascular Disease Market, By Disease Area |
6.1.1 Overview and Analysis |
6.1.2 Thailand Atherosclerotic Cardiovascular Disease Market Revenues & Volume, By Disease Area, 2021 - 2031F |
6.1.3 Thailand Atherosclerotic Cardiovascular Disease Market Revenues & Volume, By Atherosclerosis, 2021 - 2031F |
6.1.4 Thailand Atherosclerotic Cardiovascular Disease Market Revenues & Volume, By Coronary Artery Disease, 2021 - 2031F |
6.1.5 Thailand Atherosclerotic Cardiovascular Disease Market Revenues & Volume, By Heart Attack, 2021 - 2031F |
6.2 Thailand Atherosclerotic Cardiovascular Disease Market, By Treatment Type |
6.2.1 Overview and Analysis |
6.2.2 Thailand Atherosclerotic Cardiovascular Disease Market Revenues & Volume, By Medical Therapy, 2021 - 2031F |
6.2.3 Thailand Atherosclerotic Cardiovascular Disease Market Revenues & Volume, By Surgical Therapy, 2021 - 2031F |
6.2.4 Thailand Atherosclerotic Cardiovascular Disease Market Revenues & Volume, By Preventive Medicine, 2021 - 2031F |
6.3 Thailand Atherosclerotic Cardiovascular Disease Market, By Therapeutic Approach |
6.3.1 Overview and Analysis |
6.3.2 Thailand Atherosclerotic Cardiovascular Disease Market Revenues & Volume, By Statins, 2021 - 2031F |
6.3.3 Thailand Atherosclerotic Cardiovascular Disease Market Revenues & Volume, By Angioplasty, 2021 - 2031F |
6.3.4 Thailand Atherosclerotic Cardiovascular Disease Market Revenues & Volume, By Beta-blockers, 2021 - 2031F |
6.4 Thailand Atherosclerotic Cardiovascular Disease Market, By Risk Factors |
6.4.1 Overview and Analysis |
6.4.2 Thailand Atherosclerotic Cardiovascular Disease Market Revenues & Volume, By Obesity, 2021 - 2031F |
6.4.3 Thailand Atherosclerotic Cardiovascular Disease Market Revenues & Volume, By Hypertension, 2021 - 2031F |
6.4.4 Thailand Atherosclerotic Cardiovascular Disease Market Revenues & Volume, By Diabetes, 2021 - 2031F |
7 Thailand Atherosclerotic Cardiovascular Disease Market Import-Export Trade Statistics |
7.1 Thailand Atherosclerotic Cardiovascular Disease Market Export to Major Countries |
7.2 Thailand Atherosclerotic Cardiovascular Disease Market Imports from Major Countries |
8 Thailand Atherosclerotic Cardiovascular Disease Market Key Performance Indicators |
8.1 Average wait time for cardiovascular disease diagnosis and treatment. |
8.2 Percentage of the population screened for cardiovascular disease risk factors. |
8.3 Adoption rate of innovative cardiovascular disease treatment methods. |
8.4 Patient satisfaction scores with cardiovascular disease care services. |
8.5 Rate of adherence to recommended lifestyle changes among individuals at risk for atherosclerotic cardiovascular diseases. |
9 Thailand Atherosclerotic Cardiovascular Disease Market - Opportunity Assessment |
9.1 Thailand Atherosclerotic Cardiovascular Disease Market Opportunity Assessment, By Disease Area, 2021 & 2031F |
9.2 Thailand Atherosclerotic Cardiovascular Disease Market Opportunity Assessment, By Treatment Type, 2021 & 2031F |
9.3 Thailand Atherosclerotic Cardiovascular Disease Market Opportunity Assessment, By Therapeutic Approach, 2021 & 2031F |
9.4 Thailand Atherosclerotic Cardiovascular Disease Market Opportunity Assessment, By Risk Factors, 2021 & 2031F |
10 Thailand Atherosclerotic Cardiovascular Disease Market - Competitive Landscape |
10.1 Thailand Atherosclerotic Cardiovascular Disease Market Revenue Share, By Companies, 2024 |
10.2 Thailand Atherosclerotic Cardiovascular Disease Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here